HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients

BACKGROUND: Serum quantitative hepatitis B surface antigen (HBsAg) levels may be an important predictor of hepatitis B e antigen (HBeAg) seroconversion (SC) in HBeAg-positive chronic hepatitis B (CHB) patients during antiviral treatment. The pattern of HBsAg variation in CHB patients either with or...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiezuan, Chen, Jiajia, Ye, Ping, Jin, Linfeng, Wu, Wei, Sheng, Guoping, Li, Lan-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230803/
https://www.ncbi.nlm.nih.gov/pubmed/24962263
http://dx.doi.org/10.1186/1479-5876-12-183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230803/
https://www.ncbi.nlm.nih.gov/pubmed/24962263
http://dx.doi.org/10.1186/1479-5876-12-183

Ejemplares similares